A series of renal-adrenal interactions involving the pressor peptide angiotensin may control sodium balance and blood pressure in normal man (1) . Evidence for this is derived from numerous experiments in man (2-4) and animals (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) .
We propose a mechanism whereby the kidney, when its perfusion is threatened, releases renin. Renin liberates angiotensin from a specific circulating globulin. Angiotensin, in turn, stimulates the secretion of aldosterone by the adrenal cortex. Angiotensin and aldosterone, by increasing arterial pressure and renal sodium retention, help restore renal perfusion, thus compensating the system.
Although it has been demonstrated repeatedly that infused angiotensin stimulates the secretion of aldosterone and causes renal retention of sodium, we do not know if the release of endogenous angiotensin is normally associated with the release of aldosterone. Most of our speculation concerning angiotensin as a trophic hormone for aldosterone is derived from studies of the pathological hypersecretion of aldosterone. Angiotensin is implicated in disorders such as malignant hypertension (1, 2) and the edematous states of cirrhosis, nephrosis, and heart failure (18) because they are usually associated with-renal damage and hypertension or abnormal renal electrolyte behavior. 1 was given, and the full cooperation of the subjects was obtained.
The studies were conducted on the metabolism ward where all subjects received a constant daily diet of known electrolyte content. All subjects received the control diet for at least 6 days before study. Normal patients were maintained on either normal or low sodium diets, the electrolyte composition of which is given in Table I .
All subjects received infusions of angiotensin and norepinephrine in 5% dextrose solution at a rate of approximately 0.5 ml per minute, held constant by a Bowman pump.
Sphygmomanometric blood pressures were recorded at 1-hour intervals during the day and 2-hour intervals at night. We have defined pressor infusions as an elevation to 150/100; nonpressor is a minimal elevation in both systolic and diastolic pressure. Throughout the study patients were permitted limited ambulation and lavatory privileges, since infusions were made through a 12-foot tube. Metabolic ward technics and the procedures for the routine analysis of plasma and urinary electrolytes have been described elsewhere (2) . Many of our basal aldosterone secretory rates were obtained by 24-hour infusions of 5% dextrose without added pressor agent.
Aldosterone secretory rates were determined by an isotope dilution technic. 7 or 1, 2, tritium-labeled aldosterone was obtained from the U. S. Public Health Service (SA, 20 and 100 ptc per /Ag). Each batch was checked for purity and stability at monthly intervals by a) addition Effects on arterial blood pressure Normal subjects; normal sodium. As in other reports, angiotensin was about ten times more potent (by weight) than norepinephrine in producing a given rise in arterial pressure. In general, it had a greater effect on the diastolic pressure than did norepinephrine (25) . During prolonged infusions all four subjects became increasingly sensitive to the pressor effects of angiotensin as the drug concurrently produced sodium and water retention (Table III, Figures 1 and 2 ). Thus blood pressure was maintained with progressively diminishing doses of angiotensin. An increase in potassium intake did not modify the pressor response of one normal subject (no. 5).
In sharp contrast, norepinephrine produced little or no sodium retention, and increasing rather than decreasing doses of pressor agent were required to maintain the pressor response of three normal subjects (Table III, Figure 3 ). Normal subjects; low sodium. CAPE." Subject A. S. had been on a low sodium diet for several weeks before the study began. E. H. had been on a normal sodium intake for about the same period. In the salt-depleted subject, pressor sensitivity to angiotensin did not change during a 6-day infusion. It continued to stimulate increased aldosterone secretion, but there were no significant changes in electrolyte balance. In contrast, in the subject receiving a normal salt diet angiotensin produced a positive sodium balance. With this, a markedly increased pressor sensitivity developed so that at the end of an 11-day period relatively minute doses of angiotensin were required to maintain the mild pressor response. "Escape" from sodium retention began on day 5. As her angiotensin dosage was reduced, aldosterone secretion diminished falling almost back to the control levels. These data suggest a normal homeostatic interaction between the state of salt balance and the pressor and the aldosterone stimulating effects of angiotensin.
siveness to either agent appeared, but dosages of both agents required further increases on the second day of each 2-day infusion study (Table  III) .
Patients with cirrhosis and ascites. On the average these patients had a fourfold reduction in pressor sensitivity to angiotensin (Table II In R. P., a mildly pressor dose of angiotensin induced a marked and selective increase in adrenal cortical secretion of aldosterone together with a moderate degree of sodium retention for 4 days. Because of increasing pressor sensitivity to angiotensin, dosage was reduced, and aldosterone secretion returned toward control levels. "Escape" from more renal sodium retention occurred here as levels of the sodium-retaining substances, angiotensin and aldosterone, declined, but at this point blood pressure remained mildly elevated. In subject J. E. angiotensin produced persistent hypersecretion of aldosterone, and at this high dosage level it also stimulated cortisol secretion. As in the other normal subjects, sensitivity to angiotensin increased as sodium retention progressed. In this particular study it was not clear why sodium re In normal subjects on a diet containing 70 mEq of sodium, prolonged infusion of norepinephrine in pressor dosage was not associated with tachyphylaxis in subject E. P., but in subject J. E. graded increases in doses were required. In both studies, a mild natriuresis was produced followed by a period of salt retention. The transient natriuresis was accompanied by a relatively greater increase in urinary volume. In both studies these effects may have accounted for the mild hypernatremia and weight loss. There were no significant effects on aldosterone or cortisol secretion in subject E. P. In subject J. E. norepinephrine produced a rise in both cortisol and aldosterone secretion, possibly suggesting that a release of ACTH had occurred. (Figures 1 and 2) . Aldosterone secretion or excretion rates usually returned to control levels when measured 2 to 3 days after cessation of an infusion.
In contrast, norepinephrine infusions produced no consistent changes in aldosterone secretion during either three brief or three more prolonged infusion studies (Table I, Figure 3) . Normal subjects; low sodium. A significant stimulating effect of angiotensin on aldosterone secretion was apparent after prior sodium depletion in seven of the eight brief infusion studies (Table  I ). The already elevated control values were augmented by from 43 to 116%o (mean + 97%o). Both before and after sodium depletion fairly similar dosages of angiotensin were given, and similar absolute rates of aldosterone secretion were attained. Therefore, after sodium depletion the increment in aldosterone secretion appeared to be blunted in proportion to the degree of underlying increase in endogenous aldosterone secretion. Mean angiotensin-induced increments in aldosterone secretion rates were + 650 ,ug per day before sodium depletion and only + 350 ug per day after depletion (Table I) . After several weeks of sodium deprivation, aldosterone was persistently augmented in Subject no. 7 during a 6-day infusion study (A.S., Figure 1 ).
Patients with cirrhosis and ascites. It is clear that angiotensin did not increase aldosterone secretion in cirrhosis to anywhere near the extent observed in normal subjects. Secretion was generally already elevated to some extent, and in general, the lower the initial rate of aldosterone secretion the higher the increment in secretion. However, these increases resulted from doses of SOmEq Unlike normal subjects angiotensin infusion produced natriuresis and diuresis on the first day of the infusion whether or not sodium depletion had been imposed. In both studies aldosterone continued to be increased above normal control levels for as long as the infusion was applied. Angiotensin stimulated aldosterone secretion without also causing an increase in cortisol secretion. In a later study, with norepinephrine, aldosterone secretion was not affected. Pressor sensitivity to angiotensin was reduced after sodium depletion. Unlike normal subjects prolonged infusion of angiotensin was associated with neither sodium retention nor increasing pressor sensitivity.
angiotensin far in excess of those given to normal subjects. At the dose level commonly employed for normal subjects we saw little or no effect.
Several diverse effects should be noted. Two patients (no. 12 and no. 16) showed increases in aldosterone in control periods while being maintained on low sodium diets and subsequent to diuresis induced by angiotensin. Two patients (no. 11 and no. 18), who did not show secondary aldosteronism in connection with cirrhosis, also did not show any increases in aldosterone secretion with angiotensin. This is the first time we have ever observed the failure of angiotensin to increase low secretory rates of aldosterone. When dexamethasone was given to two patients to suppress ACTH release, angiotensin augmented aldosterone secretion without modifying their negligible rates of cortisol secretion.
Equipressor amounts of norepinephrine reduced aldosterone secretion in six infusions and had no significant effect in three infusions (Table II, Figure 6 ).
Effects on cortisol secretion (Tables I and II Angiotensin did not produce any uniform or striking effects on cortisol secretion in normal subjects. Figure 2 shows that one subject showed a 100% increase after prolonged infusion. However, two other subjects experienced no effect (Figures 1 and 2) .
Norepinephrine did not stimulate cortisol secretion in four infusion studies of normal subjects on normal sodium intake (Table I and Figure 3) .
In cirrhosis, the comparatively large doses of angiotensin that were administered produced impressive increases in cortisol secretion without any great increases in aldosterone secretion (Table II). A similar pattern obtained in one cirrhotic patient given norepinephrine.
Effects on plasma electrolytes and sodium and potassium balance Normal subjects; normal sodium. Except for Subject no. 5, brief infusions of angiotensin always produced renal retention of sodium. Prolonged infusions from 6 to 11 days also produced moderate sodium and water retention in all four subjects. The positive sodium balance during prolonged infusions ranged from 90 to 265 mEq (average maximum: 200 mEq). This retention was accompanied by a weight gain of 1 to 2.5 kg, but edema was never clinically detectable. These patients showed the so-called "escape" from renal retention, when, after 3 to 5 days of sodium retention, there was a tendency to excrete more sodium. At the termination of the infusions the positive sodium balances ranged from Figure 3 . Normal subjects; low sodium. In seven of eight brief infusions angiotensin did not usually modify the low rate of sodium excretion. One patient (no. 7) did show a slight sodium diuresis. However, this subject (A.S., Figure 1 ) exhibited no change in fluid and electrolyte balance during 6 days of mildly pressor infusion. After 2 months of salt deprivation, he received a higher somewhat more pressor dosage (2.2 ,ug per minute). This time a mild natriuresis occurred on the first day followed by a decrease in pressor response, (Table  I, no. 7, and Table III) . Brief infusions of norepinephrine in four sodium-depleted subjects caused no change in three and a mild natriuresis in one (Table I) . In one subject a 2-day infusion of norepinephrine continued to produce mild natriuresis with slightly declining pressor sensitivity (Table III) Figure 4 ). Natriuresis in two subjects was accompanied by significant hyponatremia. Negative potassium balance accompanied natriuresis (increments of 20 to 80 mEq per day) during seven studies of four patients. Nine brief infusions of equipressor amounts of norepinephrine caused much smaller increases in sodium excretion. Only three patients showed significant natriuresis, the average increases being 33 mEq per day (range, 7 to 54 mEq per day) (Table II) . Prolonged infusions lasting up to 4 days produced a mild diminishing natriuresis with a maximal loss of 94 mEq in 4 days in two of the five studies. Plasma electrolytes were not changed. The differences between norepinephrine and angiotensin in cirrhosis are illustrated in Figure 6 .
Untoward effects. During the sixth day of a continuous angiotensin infusion a 36-year-old normal volunteer (no. 4) suffered a cerebral hemorrhage and expired within 24 hours. The episode occurred while straining at stool. Autopsy confirmed the diagnosis, but the ruptured cerebral vessel could not be located. There was no evidence of gross or microscopic damage to the cerebral vessels or pre-existing vascular injury. The heart, kidneys, and adrenals were entirely normal histologically. Blood pressure was 180/100 a few minutes before this accident occurred.
This man, receiving 80 mEq of sodium daily, had demonstrated sodium retention (265 mEq in 5 days) and then began to "escape" with urinary sodium excretion rising from a low of 2 mEq per day on day 2 to 127 mEq per day on day 6. Possibly this sodium retention predisposed to a subtle but serial rise in pressor sensitivity, leading to an inordinate rise in blood pressure during straining. Pressure rises from angiotensin or norepinephrine have not heretofore been related to cerebral bleeding in extensive studies of animals and man. Throughout this study the infusion rate was 1.5 ,ug per minute, a rate well below that employed in other reports (26) (27) (28) (29) (30) (31) (32) (33) (34) . Because of this occurrence, this study and all other investigations with infusions of pressor agents were terminated immediately.
In general, blood pressure responses occurred within 1 to 2 minutes after the infusion of either agent. Usually, patients were unaware of the change in blood pressure; some noted occasional palpitation, but none had chest pain. Transient headache was occasionally observed with pressor doses of both drugs. No serious cardiac arrhythmias were encountered, although there were very occasional extrasystoles. When infusion of either agent ceased, there was almost always a period of hypotension that was more pronounced after prolonged infusions. The fall in blood pressure was principally orthostatic and lasted about 1 to 6 hours. A "weaning" period was often necessary after some of the more prolonged infusions in cirrhosis, lasting about several hours, but occasionally as long as several days.
Discussion
Our experiments with prolonged infusions of angiotensin appear to establish several facts. The prolonged aldosterone hypersecretion secondary to the infusion of angiotensin produces slightly different physiological changes than those previously described for the continued administration of aldosterone (35) . Infusion of angiotensin produces more immediate and impressive increases in arterial blood pressure; it produces hyponatremia instead of hypernatremia and shows less tendency for potassium wastage and alkalosis. Therefore, while the administration of aldosterone duplicates the abnormalities found in primary aldosteronism, the effects of angiotensin infusion appear to resemble those of aldosteronism associated with malignant nephrosclerosis (2). Thus, angiotensin and aldosterone cannot be equated as physiological agents, but we have obtained considerable evidence indicating that angiotensin could operate as a trophic hormone for the stimulation of aldos-terone secretion, in the mechanism outlined in the introduction.
In normal subjects angiotensin stimulated aldosterone secretion selectively and persistently, in lower, mildly pressor doses. Small doses of angiotensin stimulate aldosterone secretion exclusively; at larger dose levels where aldosterone secretion cannot be further increased, cortisol stimulation occurs (Figure 7 ). This pattern of adrenal cortical responsiveness is the opposite of that seen with ACTH, where cortisol secretion is selectively stimulated at lower doses and aldosterone stimulation occurs at higher levels after cortisol secretion approaches a maximum. Although angiotensin has a direct stimulating effect on the adrenal cortex (14-16), a subtle discharge of ACTH may have been responsible for the occasionally observed rise in cortisol secretion. Evidence for this was obtained in the two cirrhotic patients in whom dexamethasone suppression blocked the usual cortisol stimulating effect of higher angiotensin dosage.
As in previous reports (3, 4, 28) , the dosages of angiotensin required to stimulate aldosterone secretion nearly always were sufficient to produce small but definite increases in arterial blood pressure. In one report in which nonpressor amounts of angiotensin were said to stimulate aldosterone, significant elevations of pressure were described (4). We observed stimulation of aldosterone secretion with nonpressor dosages of angiotensin only once in these experiments. Otherwise the bulk of our data indicates that dosages exceeding 0.2 ug per minute of angiotensin were required to produce significant stimulation of aldosterone secretion. At this level pressor effects were small but evident.
The stimulation of aldosterone secretion by angiotensin therefore appears to be closely associated with its pressor action. However, pressor agents, in general, do not stimulate aldosterone secretion. Norepinephrine and other pressor agents (3) produce only slight and variable effects on aldosterone secretion. Moreover, the data presented in this paper indicate that both the pressor activity and the aldosterone stimulating activity of exogenous angiotensin are related to sodium balance. We could not demonstrate this or any similar relationship with norepinephrine.
In this study stimulation of aldosterone secretion by angiotensin continued for as long as the drug was applied and returned to control levels when application ceased. In contrast, in sheep the stimulating effect of angiotensin on aldosterone secretion did not persist after 6 hours (16). However, a sustained stimulation for many days in dogs receiving nonpressor infusions has been reported (19) . The ineffectiveness of nonpressor dosages in stimulating aldosterone secretion in man may perhaps be explained by a species difference. Man appears quantitatively more sensitive than animals to the pressor effects of angiotensin (19, 36) . There appeared to be a limit to the increases that angiotensin can effect on aldosterone secretion. Aldosterone secretion rates were increased to approximately the same absolute levels both before and after sodium deprivation. The peptide therefore had relatively less augmenting effect in sodium-depleted subjects in whom aldosterone secretion was already elevated. Angiotensin failed completely to increase the often high aldosterone secretion of patients with cirrhosis and ascites, even though the much larger doses given to these patients increased cortisol secretion. The partial aldosterone response of sodium-depleted normal subjects and the total lack of response in cirrhosis and ascites point to a ceiling for adrenal response to angiotensin. Increased endogenous angiotensin might be the basis for the elevated aldosterone secretion that occurs naturally in both of these situations. Pre-existing angiotensinemia could explain the blunted aldosterone response of the sodium-depleted normal subjects. A still higher endogenous level of angiotensin in cirrhosis would account for the total failure of infused angiotensin to stimulate aldosterone secretion.
Differences between the pressor sensitivity to angiotensin and norepinephrine were observed that seemed to be related to the different effects of the two agents on sodium balance. In normal subjects, angiotensin produced sustained sodium chloride retention. This was regularly accompanied by a graded increase in pressor sensitivity. In contrast, norepinephrine caused either natriuresis or no significant change in sodium balance, and pressor sensitivity tended to diminish as the infusion proceeded. In acute experiments norepinephrine too causes renal sodium retention (25) , but the present study indicates that an early escape from this effect occurs. Increasing vascular sensitivity to prolonged angiotensin infusion was also recently described in rabbits (37) . This phenomenon was not related to sodium balance.
In general, sodium depletion diminishes pressor responsiveness and enhances the effectiveness of antipressor drugs. Thus, pressor sensitivity to both angiotensin and norepinephrine was reduced somewhat after sodium depletion of normal subjects and to a greater extent in cirrhosis with ascites (Table III) . These patients were particularly insensitive to angiotensin and tended to become increasingly unresponsive (i.e., to develop tachyphylaxis). This phenomenon seemed quantitatively related to the considerably greater natriuresis induced by the peptide as compared with norepinephrine. That sodium balance may be an important determinant of pressor sensitivity is further suggested by similar prolonged infusion studies of a hypertensive subject ( Figure 5 ).
The state of sodium metabolism, therefore, seems important in determining pressor responsiveness, but the amount of angiotensin administered may also be involved. Tachyphylaxis was observed only in the six cirrhotic patients given dosages of 2.4 Mg per minute or more. However, a dose of 2.8 pg per minute did not induce tachyphylaxis in a normal subject (J. E., Figure  2 ). This possible relationship to dosage may be similar to that reported in dogs (38) and in rabbits (36) .
Patients with cirrhosis and ascites have large increases in body sodium content. Yet, in pressor responsiveness they behaved as though severely sodium depleted. This finding, together with the fact that the angiotensin-induced sodium accumulation of normal subjects actually increased pressor sensitivity to angiotensin, suggests that the abnormal distribution of retained sodium in edematous patients precludes it from supporting the action of pressor agents. Both the tendency to transudation in cirrhosis and the lack of edema in association with angiotensin-induced sodium accumulation of normal subjects suggest that the sodium retention of normal subjects increases pressor sensitivity by contributing to the volume or composition of the intravascular bed. The declining pressor sensitivity of edematous subjects during angiotensin natriuresis may have resulted from a further depletion of this intravascular sodium store.
In normal subjects as angiotensin caused sodium retention, pressor sensitivity increased to a point where the pressure elevation could be maintained by smaller dosages, which might not be expected to stimulate increased aldosterone secretion. This phenomenon might be relevant to the problem of hypertension associated with unilateral renal disease. In this condition one group has consistently found increased angiotensin release from the damaged kidney. Usually there was no attendant evidence of hyperaldosteronism (39) . The amounts of angiotensin released by these patients might conceivably suffice to maintain hypertension (after sodium retention had been induced) without being sufficient to also maintain aldosteronism. This explanation might be in accord with Tobian's hypothesis of an increased sodium content of the arterial wall in experimental hypertension (40) .
If the renin-angiotensin-aldosterone system is oriented to prevent salt depletion or arterial hypotension, the paradoxical natriuresis observed after larger, more pressor dosages of angiotensin in cirrhosis requires an explanation. This latter effect might result from an undue increase in arterial blood pressure in patients with a high endogenous angiotensin.1 In cirrhosis with nearly complete sodium retention the renal tubules and the adrenal cortex may be already responding maximally to an endogenous angiotensin stimulus. Administration of exogenous angiotensin in this situation exerts no further direct effect on the renal tubules or the adrenal cortex. The natriuresis therefore may be caused by the systemic pressor effects of excesses of the drug. This mechanism implies that increases of circulating levels of angiotensin and elevations of systemic blood pressure have opposing effects on renal sodium excretion. The sodium-retaining effect of lower doses of angiotensin has been repeatedly demonstrated (25) (26) (27) . Also, elevations of arterial pressure per se can promote natriuresis in normal animals, (4648) and more specifically in patients with cirrhosis and ascites (25, 49) . Furthermore, patients with arterial hypertension ( Figure 5 ) are much more prone than normal subjects to natriuresis when various pressor agents are infused (28, 30) . Saline-loaded normal subjects can develop this natriuretic response to pressor infusions (50) .
Operation of this interaction may provide an explanation for the mysterious "escape" from renal sodium retention induced by angiotensin in our normal subjects and also described in the dog (19) . Sodium chloride retention of the order of + 90 to + 265 mEq was produced during the first 3 to 5 days of angiotensin infusions in subjects receiving a normal sodium intake. Escape from this renal sodium retention may be a "pressure" natriuresis resulting from the attainment of a critical increment in arterial pressure that overcomes the angiotensin-aldosterone initiated sodium retention.
Borst and Borst-de-Geus (51) have proposed that the "escape" phenomenon observed in normal subjects during mineralocorticoid administration is induced by a critical rise in arterial blood pressure resulting from sodium retention. Although their hypothesis may also prove correct, no consistent rise in arterial pressure was observed during this type of "escape" in a study of 17 normal subjects (52 (37) have recently suggested that angiotensin is a specific cerebral vasoconstrictor. If this is so, it could play a role, not only in the pathogenesis of arterial hypertension, but also in the production of the associated encephalopathic syndromes and cerebral accidents. Because of the vascular acci-2.5 3.0 dent described herein infusion of all pressor agents in man should be approached with this possibility in mind until mechanisms can be worked out by further animal investigation.
Our data indicate that angiotensin is oriented to prevent sodium depletion or arterial hypotension. Loss of body sodium is associated with a tendency for a fall in arterial pressure; either may elicit the secretion of renin and the elaboration of angiotensin. Angiotensin then promotes salt retention both directly and by augmenting aldosterone secretion; as sodium stores increase, pressor sensitivity to angiotensin rises, leading to blood pressure elevation. Increased renin and aldosterone activity are then suppressed. If blood pressure rises excessively "pressure natriuresis" occurs, returning the sodium stores and blood pressure toward normal.
Summary
To obtain more information about a possible angiotensin-aldosterone interaction for regulation of sodium balance and arterial blood pressure, the effects of prolonged infusions of angiotensin and norepinephrine on blood pressure, electrolyte balance, and adrenal secretion rates of aldosterone and cortisol were studied in normal subjects and in a representative form of secondary hyperaldosteronism.
In normal subjects, norepinephrine in pressor dosage for 2 to 4 days usually produced transient natriuresis and diuresis associated with diminishing pressor responsiveness. In patients with cirrhosis, norepinephrine at times also produced significant, although transient, natriuresis and diuresis. Pressor responsiveness was reduced, but tachyphylaxis was not impressive.
Angiotensin produced quite different effects. In normal subjects an initial marked renal retention of sodium chloride occurred, paralleled by increasing pressor sensitivity. After the initial 3-to 5-day period "escape" occurred with increased renal salt excretion and a tendency for the weight to stabilize. Angiotensin also produced prompt and sustained increases in aldosterone but not in cortisol secretion. In sodium-depleted normal subjects sodium accumulation was prevented, and pressor responsiveness remained reduced.
In cirrhosis with ascites angiotensin often produced a striking natriuresis with diuresis of edema.
These patients exhibited pressor unresponsiveness and tachyphylaxis to angiotensin.
The stimulating capacity of exogenous angiotensin on aldosterone secretion was a graded one, related directly to the state of sodium balance and inversely to the pre-existing rate of aldosterone secretion. In normal subjects angiotensin augmented aldosterone secretion by a mean of 360%o before and by only 97% after sodium depletion. In cirrhosis, larger doses of angiotensin failed completely to increase the already high aldosterone secretion. But these larger dosages were capable of increasing cortisol secretion.
Our findings indicate that the state of sodium balance is an important determinant of vascular responsiveness to both pressor agents. However, a direct, internally controlled relationship between the vasoactivity of angiotensin and the state of sodium balance was suggested because in normal subjects pressor sensitivity increased with an angiotensin-induced sodium retention, and it decreased after sodium depletion. Also the pressor unresponsiveness of cirrhosis became enhanced, and tachyphylaxis often developed after angiotensin natriuresis.
The data imply that under a certain circumstance, angiotensin-induced sodium retention, pressor sensitivity may increase so that hypertension can be sustained by amounts of angiotensin insufficient to also stimulate aldosterone. This point may be relevant to the pathogenesis of certain hypertensive states. Angiotensin meets certain major criteria for an aldosterone-stimulating hormone because its action on the adrenal cortex appeared selective and persistent, and it could be demonstrated in mildly pressor dosage. Because of this and because the vasoactivity of angiotensin interacted with the state of sodium metabolism, a mechanism has been proposed in which angiotensin release participates, with aldosterone, in normal regulation of sodium balance and arterial blood pressure. The angiotensin-induced "escape" observed in the normal subjects and the paradoxical natriuresis observed in patients with cirrhosis might be explained in terms of this proposed mechanism.
